Light Bridge Healthcare Research Inc is categorized under Biological Research in San Antonio, TX and active since 2000.
Light Bridge Healthcare Research Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Thomas B Elin at the company’s single location by writing to 2726 Nacogdoches Road, San Antonio, Texas TX 78217 or by phoning (210) 824-8240. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Light Bridge Healthcare Research Inc |
| Contact Person: | Thomas B Elin |
| Address: | 2726 Nacogdoches Road, San Antonio, Texas 78217 |
| Phone Number: | (210) 824-8240 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Light Bridge Healthcare Research Inc was started in 2000 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Thomas B Elin for inquiries that concern Light Bridge Healthcare Research Inc by calling the company number (210) 824-8240, as your correspondence is most welcome. Additionally, the physical location of the single location of Light Bridge Healthcare Research Inc can be found at the coordinates as well as the street address 2726 Nacogdoches Road in San Antonio, Texas 78217.
For its online presence, you may visit Light Bridge Healthcare Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.